Cover Image
市場調查報告書

老年癡呆症診斷檢查裝置:醫療設備的開發平台評估

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 351350
出版日期 內容資訊 英文 378 Pages
訂單完成後即時交付
價格
Back to Top
老年癡呆症診斷檢查裝置:醫療設備的開發平台評估 Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月12日 內容資訊: 英文 378 Pages
簡介

本報告提供老年癡呆症診斷檢查裝置的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 老年癡呆症診斷檢查裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 老年癡呆症診斷檢查裝置 - 正在開發的開發中產品:各企業

  • 老年癡呆症診斷檢查裝置的開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 老年癡呆症診斷檢查裝置的開發企業與產品概要

  • AC Immune SA
  • Acobiom
  • Acumen Pharmaceuticals, Inc.
  • Adlyfe Inc.
  • Advanced Genomic Technology, LLC
  • ADx NeuroSciences NV
  • Akrivis Technologies, LLC
  • Alere Inc.
  • Alzhyme Pty Ltd
  • Amarantus Bioscience Holdings, Inc.
  • Applied Proteomics, Inc.
  • Araclon Biotech, S.L.
  • Banyan Biomarkers, Inc.
  • BioArctic Neuroscience AB
  • biOasis Technologies Inc.
  • Biomedical Development Corporation
  • BioSystems International
  • C2N Diagnostics LLC
  • Chronix Biomedical, Inc.
  • Cognoptix, Inc.
  • Columbia University
  • CompanDX Ltd.
  • Consejo Superior de Investigaciones Cientificas
  • Cymedx
  • DiaGenic ASA
  • DiamiR LLC
  • DiaPat GmbH
  • Diaxonhit S.A.
  • Dr. Grossegger & Drbal GmbH
  • DS Pharma Biomedical Co., Ltd.
  • Durin Technologies, Inc.
  • Emory University
  • Fianostics GmbH
  • Gene Solutions LLC
  • GeneNews Limited
  • Genentech, Inc.
  • Georg-August-Universitat Gottingen
  • Ghent University
  • HealthTell, Inc.
  • ICDD-sas
  • Innovative California Biosciences International, Inc.
  • Innovative Health Diagnostics
  • Institut National de la Sante et de la Recherche Medicale
  • Instituto de Estructura de la Materia
  • Integrated Diagnostics Inc.
  • Janssen Pharmaceutica N.V.
  • KineMed, Inc.
  • Laboratory Corporation of America Holdings
  • McGill University Health Center
  • Memory Dx, LLC
  • Meso Scale Diagnostics LLC
  • Myriad Genetics, Inc.
  • NanoSomiX, Inc.
  • Nanosphere, Inc.
  • Neuron Biopharma SA
  • NeuroQuest, Ltd.
  • Neurotrope Bioscience, Inc.
  • NeuroVision Imaging LLC.
  • Newcastle University
  • NextGen Sciences Dx Inc
  • Novel Bio-spectrum Technologies, Inc.
  • Oligomerix, inc.
  • OPKO Health, Inc.
  • Orasi Medical, Inc.
  • Oregon Health & Science University
  • Oryzon Genomics S.A.
  • Oxford Biodynamics Limited
  • PDx BioTech
  • PeriRx LLC
  • Pre Diagnostics AS
  • Predemtec GmbH
  • ProMIS Neurosciences Inc.
  • Proplex Technologies, Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomics International Pty Ltd
  • Quanterix Corporation
  • Redox Diagnostics LLC
  • Saladax Biomedical, Inc.
  • Satoris, Inc.
  • Scout Diagnostics, LLC
  • Singulex, Inc.
  • SomaLogic, Inc.
  • Takeda Pharmaceuticals International AG
  • The Johns Hopkins University
  • The University of Melbourne
  • Trinity College Dublin
  • True Diagnostics, Inc.
  • University of California, Irvine
  • University of Chicago
  • University of Georgia
  • University of Luxembourg
  • University of Nottingham
  • University of South Florida
  • University of Texas Health Science Center at Houston
  • University of Texas Southwestern Medical Center at Dallas
  • US Biomarkers, Inc.
  • Vermillion, Inc.
  • Vitruvian Biomedical, Inc.
  • Washington University in St. Louis
  • XRGenomics LTD
  • Zoiray Technologies Inc.

第6章 老年癡呆症診斷檢查裝置 - 最近的事件

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0447EPD

GlobalData's Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Alzheimer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 17

2 Introduction 18

  • 2.1 Alzheimer Diagnostic Tests Overview 18

3 Products under Development 19

  • 3.1 Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 19
  • 3.2 Alzheimer Diagnostic Tests - Pipeline Products by Territory 20
  • 3.3 Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 21
  • 3.4 Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 22
  • 3.5 Alzheimer Diagnostic Tests - Ongoing Clinical Trials 23

4 Alzheimer Diagnostic Tests - Pipeline Products under Development by Companies 24

  • 4.1 Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 24
  • 4.2 Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 29

5 Alzheimer Diagnostic Tests Companies and Product Overview 34

  • 5.1 AC Immune SA Company Overview 34
  • 5.2 Acobiom Company Overview 36
  • 5.3 Acumen Pharmaceuticals Inc Company Overview 38
  • 5.4 Adlyfe Inc Company Overview 39
  • 5.5 Advanced Genomic Technology, LLC Company Overview 40
  • 5.6 ADx NeuroSciences NV Company Overview 41
  • 5.7 Aelan Cell Technologies Company Overview 50
  • 5.8 Akrivis Technologies LLC Company Overview 51
  • 5.9 Albert Ludwigs University of Freiburg Company Overview 52
  • 5.10 Alere Inc Company Overview 53
  • 5.11 Alzhyme Pty Ltd Company Overview 54
  • 5.12 Amarantus Bioscience Holdings Inc Company Overview 55
  • 5.13 Amoneta Diagnostics SAS Company Overview 58
  • 5.14 Amprion Inc Company Overview 59
  • 5.15 Applied NeuroSolutions, Inc. (Inactive) Company Overview 60
  • 5.16 Applied Proteomics Inc Company Overview 61
  • 5.17 Arkley Biotek LLC Company Overview 62
  • 5.18 Avant Diagnostics, Inc. Company Overview 63
  • 5.19 Banyan Biomarkers Inc Company Overview 64
  • 5.20 BioArctic AB Company Overview 65
  • 5.21 Bioasis Technologies Inc Company Overview 66
  • 5.22 Biocross SL Company Overview 67
  • 5.23 Biomedical Development Corp Company Overview 71
  • 5.24 BioSystems International Company Overview 72
  • 5.25 C2N Diagnostics LLC Company Overview 73
  • 5.26 Chronix Biomedical Inc Company Overview 74
  • 5.27 Cleveland Diagnostics Inc. Company Overview 75
  • 5.28 Cofactor Genomics Inc Company Overview 76
  • 5.29 Cognoptix Inc Company Overview 77
  • 5.30 Columbia University Company Overview 80
  • 5.31 CompanDX Ltd. Company Overview 82
  • 5.32 Consejo Superior de Investigaciones Cientificas Company Overview 83
  • 5.33 Cymedx Company Overview 84
  • 5.34 Cytox Ltd Company Overview 85
  • 5.35 DiaGenic ASA Company Overview 88
  • 5.36 DiaPat GmbH Company Overview 90
  • 5.37 Diaxonhit SA Company Overview 91
  • 5.38 Dr. Grossegger & Drbal GmbH Company Overview 92
  • 5.39 Durin Technologies, Inc. Company Overview 93
  • 5.40 EMD Millipore Corp Company Overview 94
  • 5.41 Emory University Company Overview 95
  • 5.42 Fianostics GmbH Company Overview 96
  • 5.43 Forschungszentrum Julich GmbH Company Overview 97
  • 5.44 French National Institute of Health and Medical Research Company Overview 98
  • 5.45 Fujirebio Diagnostics Inc Company Overview 99
  • 5.46 Gene Solutions LLC Company Overview 100
  • 5.47 GeneNews Ltd Company Overview 101
  • 5.48 Ghent University Company Overview 102
  • 5.49 Grifols SA Company Overview 103
  • 5.50 HealthTell Inc Company Overview 104
  • 5.51 Hummingbird Diagnostics GmbH Company Overview 105
  • 5.52 IASO BioMed Inc Company Overview 106
  • 5.53 ICDD-sas Company Overview 107
  • 5.54 Innovative Health Diagnostics Company Overview 109
  • 5.55 Instituto de Estructura de la Materia Company Overview 110
  • 5.56 Integrated Diagnostics Inc Company Overview 111
  • 5.57 Janssen Pharmaceutica NV Company Overview 112
  • 5.58 John Hopkins University Company Overview 113
  • 5.59 KineMed Inc Company Overview 114
  • 5.60 Laboratory Corp of America Holdings Company Overview 115
  • 5.61 Leibniz Institute for Age Research - Fritz Lipmann Institute Company Overview 116
  • 5.62 Luminex Corp Company Overview 117
  • 5.63 McGill University Health Center Company Overview 118
  • 5.64 Memory Dx LLC Company Overview 119
  • 5.65 Meso Scale Diagnostics LLC Company Overview 120
  • 5.66 Michigan State University Company Overview 121
  • 5.67 Myriad RBM Inc Company Overview 122
  • 5.68 NanoSomiX, Inc. Company Overview 123
  • 5.69 Nanosphere Inc Company Overview 125
  • 5.70 Neuron Biopharma SA Company Overview 126
  • 5.71 NeuroQuest Ltd Company Overview 127
  • 5.72 Neurotrope Bioscience Inc Company Overview 128
  • 5.73 Newcastle University Company Overview 129
  • 5.74 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 130
  • 5.75 Oasis Diagnostics Corp Company Overview 131
  • 5.76 Oligomerix inc Company Overview 132
  • 5.77 OPKO Health Inc Company Overview 133
  • 5.78 Orasi Medical, Inc. (Inactive) Company Overview 136
  • 5.79 Oregon Health & Science University Company Overview 137
  • 5.80 Oryzon Genomics SA Company Overview 139
  • 5.81 PeriRx LLC Company Overview 140
  • 5.82 Pre Diagnostics AS Company Overview 141
  • 5.83 Predemtec GmbH Company Overview 142
  • 5.84 ProMIS Neurosciences Inc Company Overview 143
  • 5.85 Proplex Technologies Llc Company Overview 144
  • 5.86 Protagen AG Company Overview 145
  • 5.87 Proteome Sciences Plc Company Overview 146
  • 5.88 Proteomics International Laboratories Ltd Company Overview 149
  • 5.89 Quanterix Corp Company Overview 150
  • 5.90 Redox Diagnostics LLC Company Overview 151
  • 5.91 Roche Diagnostics International Ltd Company Overview 152
  • 5.92 Rockefeller University Company Overview 153
  • 5.93 Rosetta Genomics Ltd Company Overview 154
  • 5.94 Satoris, Inc. Company Overview 155
  • 5.95 Scout Diagnostics, LLC Company Overview 156
  • 5.96 SeNostic GmbH Company Overview 157
  • 5.97 Siemens Healthcare GmbH Company Overview 158
  • 5.98 SomaLogic Inc Company Overview 160
  • 5.99 Synthetic Biologics Inc Company Overview 161
  • 5.100 Takeda Pharmaceuticals International AG Company Overview 162
  • 5.101 TauRx Pharmaceuticals Ltd Company Overview 163
  • 5.102 Trinity College Dublin Company Overview 164
  • 5.103 True Diagnostics Inc Company Overview 165
  • 5.104 University of California Irvine Company Overview 166
  • 5.105 University of Chicago Company Overview 167
  • 5.106 University of Georgia Company Overview 168
  • 5.107 University of Gottingen Company Overview 169
  • 5.108 University of Illinois at Chicago Company Overview 171
  • 5.109 University of Luxembourg Company Overview 173
  • 5.110 University of Maryland Baltimore Company Overview 174
  • 5.111 University of Melbourne Company Overview 175
  • 5.112 University of Nottingham Company Overview 176
  • 5.113 University of Oxford Company Overview 177
  • 5.114 University of South Florida Company Overview 178
  • 5.115 University of Texas Health Science Center at Houston Company Overview 179
  • 5.116 University of Texas Southwestern Medical Center Company Overview 180
  • 5.117 US Biomarkers Inc Company Overview 181
  • 5.118 vall d hebron institut de Recerca Company Overview 182
  • 5.119 Vermillion Inc Company Overview 183
  • 5.120 Vitruvian Biomedical Inc Company Overview 184
  • 5.121 Washington University in St Louis Company Overview 185
  • 5.122 Zoiray Technologies Inc. Company Overview 187

6 Alzheimer Diagnostic Tests - Recent Developments 188

  • 6.1 Aug 28, 2017: biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders 188
  • 6.2 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 190
  • 6.3 Aug 22, 2017: Clinical Study Shows that Retinal Imaging may Detect Signs of Alzheimer's Disease 191
  • 6.4 Aug 21, 2017: biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer 192
  • 6.5 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 193
  • 6.6 Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 194
  • 6.7 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 194
  • 6.8 Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 195
  • 6.9 Aug 09, 2017: AC Immune Reports Second Quarter 2017 Financial Results 197
  • 6.10 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 198
  • 6.11 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 199
  • 6.12 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results 200
  • 6.13 Aug 01, 2017: Proteome Sciences: Directorate changes 204
  • 6.14 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 204
  • 6.15 Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017 207
  • 6.16 Jul 27, 2017: Bristol-Myers Squibb Reports Second Quarter Financial Results 208
  • 6.17 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 212
  • 6.18 Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 214
  • 6.19 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 215
  • 6.20 Jul 18, 2017: LabCorp's William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 216
  • 6.21 Jul 18, 2017: Hans E. Bishop to Join Agilent's Board of Directors 216
  • 6.22 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 217
  • 6.23 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 218
  • 6.24 Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 219
  • 6.25 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China 219

7 Appendix 373

  • 7.1 Methodology 373
  • 7.2 About GlobalData 376
  • 7.3 Contact Us 376
  • 7.4 Disclaimer 376

List of Tables

1.1 List of Tables

  • Table 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 21
  • Table 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 22
  • Table 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 23
  • Table 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 24
  • Table 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 25
  • Table 6: Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 26
  • Table 7: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 31
  • Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status 36
  • Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description 36
  • Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status 37
  • Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description 37
  • Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status 38
  • Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description 38
  • Table 16: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 39
  • Table 17: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 39
  • Table 18: Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status 40
  • Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description 40
  • Table 21: Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 22: Diagnostic Assay - Alzheimer's Disease - Product Status 41
  • Table 23: Diagnostic Assay - Alzheimer's Disease - Product Description 41
  • Table 24: Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 25: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status 42
  • Table 26: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description 42
  • Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 28: ADDL'S Biomarker Test - Product Status 43
  • Table 29: ADDL'S Biomarker Test - Product Description 43
  • Table 30: APO E4 Biomarker Test - Product Status 44
  • Table 31: APO E4 Biomarker Test - Product Description 44
  • Table 32: BACE 1 Biomarker Test - Product Status 44
  • Table 33: BACE 1 Biomarker Test - Product Description 45
  • Table 34: Blood Based Amyloid Beta Biomarker Test - Product Status 45
  • Table 35: Blood Based Amyloid Beta Biomarker Test - Product Description 45
  • Table 36: Cerebrospinal Fluid Based Amyloid Beta Biomarker Test - Product Status 46
  • Table 37: Cerebrospinal Fluid Based Amyloid Beta Biomarker Test - Product Description 46
  • Table 38: GLOB. P3N AB Biomarker Test - Product Status 46
  • Table 39: GLOB. P3N AB Biomarker Test - Product Description 47
  • Table 40: Neurogranin Biomarker Test - Product Status 47
  • Table 41: Neurogranin Biomarker Test - Product Description 47
  • Table 42: O-TAU Biomarker Test - Product Status 48
  • Table 43: O-TAU Biomarker Test - Product Description 48
  • Table 44: P-tau Biomarker Test - Product Status 48
  • Table 45: P-tau Biomarker Test - Product Description 49
  • Table 46: SNAP 25 Biomarker Test - Product Status 49
  • Table 47: SNAP 25 Biomarker Test - Product Description 49
  • Table 48: Synuclein Oligo Biomarker Test - Product Status 50
  • Table 49: Synuclein Oligo Biomarker Test - Product Description 50
  • Table 50: Total tau Biomarker Test - Alzheimer's Test - Product Status 50
  • Table 51: Total tau Biomarker Test - Alzheimer's Test - Product Description 51
  • Table 52: Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 53: Diagnostic Blood Test - Alzheimer's Disease - Product Status 52
  • Table 54: Diagnostic Blood Test - Alzheimer's Disease - Product Description 52
  • Table 55: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 56: Amyloid-B Biomarker Test - Alzheimer's Disease - Product Status 53
  • Table 57: Amyloid-B Biomarker Test - Alzheimer's Disease - Product Description 53
  • Table 58: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 59: Mitochondrial Preprotein Based Test - Alzheimer's Disease - Product Status 54
  • Table 60: Mitochondrial Preprotein Based Test - Alzheimer's Disease - Product Description 54
  • Table 61: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 62: Diagnostic Assay - Alzheimer's Disease - Product Status 55
  • Table 63: Diagnostic Assay - Alzheimer's Disease - Product Description 55
  • Table 64: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 65: Diagnostic Test - Alzheimer's Disease - Product Status 56
  • Table 66: Diagnostic Test - Alzheimer's Disease - Product Description 56
  • Table 67: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 68: Georgetown Assay - Alzheimer's Disease-Exosomes - Product Status 57
  • Table 69: Georgetown Assay - Alzheimer's Disease-Exosomes - Product Description 57
  • Table 70: Georgetown Assay - Alzheimer's Disease-Lipids - Product Status 58
  • Table 71: Georgetown Assay - Alzheimer's Disease-Lipids - Product Description 58
  • Table 72: NuroPro - Alzheimer's Disease - Product Status 58
  • Table 73: NuroPro - Alzheimer's Disease - Product Description 59
  • Table 74: Amoneta Diagnostics SAS Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 75: Diagnostic Kit - Alzheimer's Disease - Product Status 60
  • Table 76: Diagnostic Kit - Alzheimer's Disease - Product Description 60
  • Table 77: Amprion Inc Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 78: Diagnostic Assay - Alzheimer's Disease - Product Status 61
  • Table 79: Diagnostic Assay - Alzheimer's Disease - Product Description 61
  • Table 80: Applied NeuroSolutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 81: P-Tau 231 Test - Product Status 62
  • Table 82: P-Tau 231 Test - Product Description 62
  • Table 83: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 84: API Diagnostic Test - Alzheimer's Disease - Product Status 63
  • Table 85: API Diagnostic Test - Alzheimer's Disease - Product Description 63
  • Table 86: Arkley Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 87: Blood Test - Alzheimer's Disease - Product Status 64
  • Table 88: Blood Test - Alzheimer's Disease - Product Description 64
  • Table 89: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 90: LymPro CLIA Test - Product Status 65
  • Table 91: LymPro CLIA Test - Product Description 65
  • Table 92: Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 93: Diagnostic Assay - Alzheimer's Disease - Product Status 66
  • Table 94: Diagnostic Assay - Alzheimer's Disease - Product Description 66
  • Table 95: BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 96: Diagnostic Test - Alzheimer's Disease - Product Status 67
  • Table 97: Diagnostic Test - Alzheimer's Disease - Product Description 67
  • Table 98: Bioasis Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 99: Cognitest - Product Status 68
  • Table 100: Cognitest - Product Description 68
  • Table 101: Biocross SL Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 102: ApoE4 Blood Marker Assay - Product Status 69
  • Table 103: ApoE4 Blood Marker Assay - Product Description 69
  • Table 104: Diagnostic Assay - Alzheimer's Disease - Product Status 70
  • Table 105: Diagnostic Assay - Alzheimer's Disease - Product Description 70
  • Table 106: Biocross SL - Ongoing Clinical Trials Overview 71
  • Table 107: ApoE4 Blood Marker Assay - Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging 72
  • Table 108: Biomedical Development Corp Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 109: Vestibular - Topographical Memory Diagnostic Test - Product Status 73
  • Table 110: Vestibular - Topographical Memory Diagnostic Test - Product Description 73
  • Table 111: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 112: Diagnostic Test - Alzheimer's Disease - Product Status 74
  • Table 113: Diagnostic Test - Alzheimer's Disease - Product Description 74
  • Table 114: C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 115: SILK-AB Assay - Product Status 75
  • Table 116: SILK-AB Assay - Product Description 75
  • Table 117: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 118: Companion Diagnostic Test - Alzheimer's Disease - Product Status 76
  • Table 119: Companion Diagnostic Test - Alzheimer's Disease - Product Description 76
  • Table 120: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 121: Blood-Based Diagnostic Test - Alzheimer's Disease - Product Status 77
  • Table 122: Blood-Based Diagnostic Test - Alzheimer's Disease - Product Description 77
  • Table 123: Cofactor Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 124: RNA Based Diagnostic Test - Alzheimer's Disease - Product Status 78
  • Table 125: RNA Based Diagnostic Test - Alzheimer's Disease - Product Description 78
  • Table 126: Cognoptix Inc Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 127: SAPPHIRE II Eye Test - Product Status 79
  • Table 128: SAPPHIRE II Eye Test - Product Description 79
  • Table 129: Cognoptix Inc - Ongoing Clinical Trials Overview 80
  • Table 130: SAPPHIRE II Eye Test - An Evaluation of Aftobetin-HCl and Fluorescence Detection as Measured by Sapphire II to Determine the Number and Timing of Administrations in Subjects with Normal Cognition, Mild Cognitive Impairment, and Mild Alzheimer's Disease 81
  • Table 131: SAPPHIRE II Eye Test - Diagnosis of Alzheimer's Disease via Beta Amyloid Signature in the Eyes Using SAPPHIRE II : A Proof Of Concept Study 81
  • Table 132: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 133: bAPP Diagnostic Test - Alzheimer's Disease - Product Status 82
  • Table 134: bAPP Diagnostic Test - Alzheimer's Disease - Product Description 82
  • Table 135: Diagnostic Test - Alzheimer's Disease - Product Status 83
  • Table 136: Diagnostic Test - Alzheimer's Disease - Product Description 83
  • Table 137: CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 138: Biomarker Assay - Alzheimer's Disease - Product Status 84
  • Table 139: Biomarker Assay - Alzheimer's Disease - Product Description 84
  • Table 140: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 141: Diagnostic Assay - Alzheimer's Disease - Product Status 85
  • Table 142: Diagnostic Assay - Alzheimer's Disease - Product Description 85
  • Table 143: Cymedx Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 144: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Status 86
  • Table 145: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Description 86
  • Table 146: Cytox Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 147: ADpredict Screening Test - Product Status 87
  • Table 148: ADpredict Screening Test - Product Description 87
  • Table 149: Cytox Ltd - Ongoing Clinical Trials Overview 88
  • Table 150: ADpredict Screening Test - Cytox Starts Clinical Evaluation Of Novel Mtor Blood Tests For Dementia 89
  • Table 151: ADpredict Screening Test - Cytox starts clinical evaluation of novel mTOR blood tests for Mild Cognitive Impairment 89
  • Table 152: DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 153: ADtect PLUS - Product Status 90
  • Table 154: ADtect PLUS - Product Description 90
  • Table 155: MCItect ULTRA - Product Status 91
  • Table 156: MCItect ULTRA - Product Description 91
  • Table 157: DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 158: DiaPat - Alzheimer's Disease Test - Product Status 92
  • Table 159: DiaPat - Alzheimer's Disease Test - Product Description 92
  • Table 160: Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview 93

List of Figures

1.2 List of Figures

  • Figure 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 21
  • Figure 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 22
  • Figure 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 23
  • Figure 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 24
  • Figure 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 25
Back to Top